Multiple Myeloma
Advertisement
Samantha Shenoy, NP, speaks about her experience at the meeting and key highlights in multiple myeloma research.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, explains key takeaways from her myeloma research at ASH 2024.
Learn how oncology nurses can assess for CRS and ICANS, which are the main side effects of CAR-T and BiTE therapies.
Oncology nurses must understand how these therapies are similar but different regarding therapy-specific side effects.
An analysis presented at ASH 2024 suggests the summation of evidence supports the therapy as a new standard of care.
The implementation of the process showed that outpatient administration is safe, well-tolerated, and reduced inpatient days.
The post hoc study analysis showed that optimized bridging therapy is critical to disease control for multiple myeloma.
Researchers studied DARA plus VRd as a new standard of care vs VRd alone in patients with newly-diagnosed multiple myeloma.
The Patient Navigation Center at the Multiple Myeloma Research Foundation addresses barriers to care and supports patients.
Talquetamab showed "robust and durable responses" for patients with relapsed/refractory multiple myeloma.
Oncology nurses may be the first to identify the classic triad of hyperviscosity syndrome symptoms.
Almost all patients with multiple myeloma at some point will develop bone disease—the “B” in CRAB.
Lisa Hwa, APRN, CNP, DNP, MS, said the comprehensive fellowships will help prepare APPs working in complex specialties.
Understanding critical symptoms in the “CRAB” acronym can enable oncology nurses to educate patients and caregivers.
Up to 50% of patients have renal insufficiency at the time of multiple myeloma diagnosis.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
Amy Pierre, RN, BSN, ANP-BC, shares her insights on disparities in myeloma and the steps APPs can take to address them.
New research highlights the need for “early and equitable” integration of palliative care for patients with myeloma.
Blood Cancer Awareness Month represents a critical opportunity to provide education on early signs and symptoms.
Amy Pierre, RN, BSN, ANP-BC, shares what the annual observance means to her and the field as a whole.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.